DIGITAL HEALTHCARE, HEALTHCARE ANALYTICS
PointClickCare | March 17, 2023
PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey, today announced the acquisition of Patient Pattern. The combination of PointClickCare and Patient Pattern will further the companies' shared vision of enabling better care and outcomes for high-needs populations and provide care teams with the solutions they need to successfully operate at the top of their license.
The shift to value-based care continues to accelerate each year, especially as providers are increasingly taking on more risk. According to a recent McKinsey and Company study, the number of patients treated within the value-based care landscape could roughly double in the next five years. Institutional Special Needs Plans (I-SNPs), demonstrate the enormous potential of aligned value-based care models.
“Senior care providers need support as they navigate new models of care and ultimately take on more risk-bearing responsibilities, inclusive of technology that helps them deliver exceptional care, particularly to high-needs populations,” said Travis Palmquist, Senior Vice President and General Manager of Senior Care at PointClickCare. “As our customers continue to embrace value-based care and see the success of this model, we are excited to deploy Patient Pattern’s care management platform. Care models will continue to evolve, and this strategic investment is another example of our commitment to helping our customers thrive in this evolving market, specifically, the opportunity to succeed with this shift to risk.”
Since its inception, PointClickCare has invested in innovation across the care continuum to close gaps in healthcare delivery through its rich and expansive insights. PointClickCare and Patient Pattern’s combined offerings provide a mechanism to adopt and succeed in risk-bearing arrangements without having to use multiple fragmented solutions. Through this acquisition, PointClickCare will further enable providers to take a comprehensive approach to frailty, ultimately providing better overall care planning.
“Over the past ten years, we’ve worked hard to integrate a care management philosophy and capabilities directly into our EHR,” said Dr. Steven Buslovich, co-founder and Chief Executive Officer at Patient Pattern. “We’re thrilled to join forces with PointClickCare as we march toward our collective goal of helping clinicians better predict and document risk, close care gaps, and improve patient outcomes. The marriage of an integrated care management platform with population health data will prove to be a major differentiator for us.”
Goodwin Procter LLP served as legal advisor and PricewaterhouseCoopers LLP served as tax and accounting advisor to PointClickCare. Nemphos Braue LLC served as legal advisor to Patient Pattern. Terms of the transaction were not disclosed.
About PointClickCare
PointClickCare is a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey. More than 27,000 long‐term and post‐acute care providers, over 2,800 hospitals and 2,000 ambulatory clinics, every major U.S. health plan across the U.S, and over 75 state and government agencies use PointClickCare, enabling care collaboration and value‐based care delivery for millions across North America.
Read More
HEALTH TECHNOLOGY
Signify Health | March 08, 2023
Cardinal Health recently announced a partnership with Signify Health to provide clinical and medication management services in-home through its OutcomesTM business. This partnership will support the prescription-to-pharmacy-to-home treatment journey for more than 2.3 million members across the US by reducing costs and eliminating care gaps.
Numerous members do not follow their prescribed medications, according to studies. By combining Signify Health's mobile network of 11,000+ credentialed clinicians with Outcomes' industry-leading OutcomesOneTM clinical care platform and omnichannel network of payers and pharmacies, this collaboration will assist in solving medication management challenges for members of the health plan. It will achieve this by providing coordinated care from Signify Health clinicians, who will also perform evaluations of those members at-home.
Signify Health can use the OutcomesOneTM platform to determine and address patients' medication therapy management requirements based on the information gathered during in-home evaluations. The collaboration will initially focus on interventions advised for Medicare Advantage members of mutual clients and may expand to include additional services, like clinical interventions and population health programs.
David Pierre, COO of Signify Health, stated, "From our experience conducting medication reviews in thousands of homes each day, we understand the importance of making medication management more convenient, accessible and connected to daily life." He added, "We look forward to joining forces with Outcomes to bring this vital service to improve medication safety and adherence and drive more value for the people we are privileged to serve."
(Source – Cision PR Newswire)
About Signify Health
Signify Health is a premier healthcare platform that empowers healthcare organizations to create and power value-based payment programs. Its mission is to build trusted relationships with patients and providers to make people healthier. The company achieves this mission by leveraging advanced analytics, technology, and nationwide healthcare provider networks. As a result, its platform helps reduce costs and eliminate gaps in care while supporting patients' treatment journey from prescription to the pharmacy to home.
Read More
HEALTH TECHNOLOGY, DIGITAL HEALTHCARE
CCS | February 02, 2023
On February 1, 2023, CCS, a leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions, announced the launch of its Scientific Advisory Council, comprised of four industry leaders who will assist CCS in its commitment to reinventing patient care at home through a more holistic approach. The Council consists of Karmeen Kulkarni, MS, RD, CD, CDCES, BC-ADM; Alexander Ding, MD, MBA; Steven Wittlin, MD; and Francine Kauffman, MD. This announcement follows the appointment of Arti Masturzo, MD, as CCS's first Chief Medical Officer.
Over 11% of the US population has been diagnosed with diabetes, which is projected to increase among American youth and young adults. Therefore, there is a great need for innovative technologies, partnerships, and services to fully support people in managing their diabetes. CCS chose to assemble its Scientific Advisory Council and assume a leadership position in redefining how health plans, providers, and employers support their patients and members impacted by costly, debilitating chronic diseases.
Additional information about the initial members of the Council is provided below
• Alexander Ding, MD, MBA, is a diagnostic and interventional radiologist, Associate VP of Physician Strategy and Medical Affairs for Humana, and an American Medical Association board member. He cultivates physician-health plan relationships and patient empowerment and engagement through digital health.
• Karmeen Kulkarni, MS, CD, RD, CDCES, BC-ADM, is a clinical pioneer in diabetes management with over 30 years of experience. She was Abbott's Global Scientific Affairs director for 15 years before starting her consulting firm. Ms. Kulkarni has unique experience integrating devices, technology, coaching, and clinical services to improve outcomes for diabetes patients.
• Steven Wittlin, MD, is an endocrinologist, published author, and University of Rochester's Director of Diabetes Services. His experience includes new diabetes treatment procedures that combine best practices in technology, medical devices, and clinical services.
• Francine Kaufman, MD, a pediatric endocrinologist, and former American Diabetes Association president, is the Chief Medical Officer at Senseonics, Inc., and previously held that position at Medtronic Diabetes. Dr. Kaufman, a key CCS Strategic Advisory Board member, will also be on the Scientific Advisory Council.
About CCS
Based in Dallas, Texas, CCS provides collaborative care programs and medical supplies delivered at home for people with chronic conditions, particularly diabetes. As a result, patients have better probabilities of starting and continuing therapy with CCS as their partner, lowering costs and enhancing outcomes. The company serves over 150,000 people in the United States with chronic conditions and delivers over 1.2 million medical products to homes yearly. With over 25 years of experience, CCS has the expertise, data, and relationships to usher in a new era of home-based, proactive chronic care management.
Read More